+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Different rates of progression and mortality in patients with chronic kidney disease at outpatient nephrology clinics across Europe

Different rates of progression and mortality in patients with chronic kidney disease at outpatient nephrology clinics across Europe

Kidney International 93(6): 1432-1441

The incidence of renal replacement therapy varies across countries. However, little is known about the epidemiology of chronic kidney disease (CKD) outcomes. Here we describe progression and mortality risk of patients with CKD but not on renal replacement therapy at outpatient nephrology clinics across Europe using individual data from nine CKD cohorts participating in the European CKD Burden Consortium. A joint model assessed the mean change in estimated glomerular filtration rate (eGFR) and mortality risk simultaneously, thereby accounting for mortality risk when estimating eGFR decline and vice versa, while also correcting for the measurement error in eGFR. Results were adjusted for important risk factors (baseline eGFR, age, sex, albuminuria, primary renal disease, diabetes, hypertension, obesity and smoking) in 27,771 patients from five countries. The adjusted mean annual eGFR decline varied from 0.77 (95% confidence interval 0.45, 1.08) ml/min/1.73m2 in the Belgium cohort to 2.43 (2.11, 2.75) ml/min/1.73m2 in the Spanish cohort. As compared to the Italian PIRP cohort, the adjusted mortality hazard ratio varied from 0.22 (0.11, 0.43) in the London LACKABO cohort to 1.30 (1.13, 1.49) in the English CRISIS cohort. These results suggest that the eGFR decline showed minor variation but mortality showed the most variation. Thus, different health care organization systems are potentially associated with differences in outcome of patients with CKD within Europe. These results can be used by policy makers to plan resources on a regional, national and European level.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 058422706

Download citation: RISBibTeXText

PMID: 29656901

DOI: 10.1016/j.kint.2018.01.008

Related references

Prevalence of cardiovascular disease among patients with chronic kidney disease in nephrology and diabetes clinics. Journal of the American Society of Nephrology 12(Program and Abstract Issue): 215A, 2001

Clinical prediction models for progression of chronic kidney disease to end-stage kidney failure under pre-dialysis nephrology care: results from the Chronic Kidney Disease Japan Cohort Study. Clinical and Experimental Nephrology 2018, 2018

Standard care in diabetic kidney disease: a survey of medical specialists in diabetes and nephrology outpatient clinics. Journal of Evaluation in Clinical Practice 16(3): 517-519, 2010

Characteristics of patients with chronic kidney disease referred to a nephrology outpatient clinic: results of Nefrodata study. Giornale Italiano di Nefrologia 32(2), 2016

Are we satisfied with the follow-up of hypertensive and chronic kidney disease patients in outpatient clinics?. Hippokratia 15(Suppl 1): 44-49, 2011

Reclassification of chronic kidney disease patients for end-stage renal disease risk by proteinuria indexed to estimated glomerular filtration rate: multicentre prospective study in nephrology clinics. Nephrology, Dialysis, Transplantation 2018, 2018

Timely Referral to Outpatient Nephrology Care Slows Progression and Reduces Treatment Costs of Chronic Kidney Diseases. Kidney International Reports 2(2): 142-151, 2016

Prevalence of chronic kidney disease and its complications in non-nephrology speciality clinics. Journal of the American Society of Nephrology 14(Abstracts Issue): 290A, 2003

Association of anthropometric measures with kidney disease progression and mortality: a retrospective cohort study of pre-dialysis chronic kidney disease patients referred to a specialist renal service. Bmc Nephrology 17(1): 74, 2017

Risk Score to Predict 1-Year Mortality after Haemodialysis Initiation in Patients with Stage 5 Chronic Kidney Disease under Predialysis Nephrology Care. Plos One 10(6): E0129180, 2016

The effect of statins on microalbuminuria, proteinuria, progression of kidney function, and all-cause mortality in patients with non-end stage chronic kidney disease: A meta-analysis. Pharmacological Research 105: 74-83, 2016

Factors associated with chronic kidney disease progression in Australian nephrology practices. Nephron. Clinical Practice 121(1-2): C36-C41, 2013

Kidney disease health literacy among new patients referred to a nephrology outpatient clinic. Internal Medicine Journal 44(11): 1080-1086, 2015

Surgically induced chronic kidney disease may be associated with a lower risk of progression and mortality than medical chronic kidney disease. Journal of Urology 189(5): 1649-1655, 2013

Impact of elevated intact parathyroid hormone on mortality and renal disease progression in patients with chronic kidney disease stages 3 and 4. Current Medical Research and Opinion 28(9): 1527-1536, 2013